Axsome Therapeutics Files Q1 2025 10-Q
Ticker: AXSM · Form: 10-Q · Filed: May 5, 2025 · CIK: 1579428
| Field | Detail |
|---|---|
| Company | Axsome Therapeutics, INC. (AXSM) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
Related Tickers: AXSM
TL;DR
AXSM Q1 2025 10-Q is in. Check financials.
AI Summary
Axsome Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company's financial statements reflect its ongoing operations and financial position. Key financial data and disclosures are provided for investors and stakeholders.
Why It Matters
This filing provides crucial financial and operational updates for Axsome Therapeutics, Inc., offering insights into the company's performance and financial health for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Axsome Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their SEC filings.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025 financial results are detailed.)
Key Players & Entities
- Axsome Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — Period of report for the 10-Q
- 20250505 (date) — Filing date of the 10-Q
- ONE WORLD TRADE CENTER, 29TH FLOOR (location) — Business and mailing address
- NEW YORK (location) — City for business and mailing address
- DE (location) — State of incorporation
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20250505.
What is Axsome Therapeutics, Inc.'s Standard Industrial Classification code?
The SIC code for Axsome Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is Axsome Therapeutics, Inc. headquartered?
The company's business and mailing address is One World Trade Center, 29th Floor, New York, NY 10007.
What is the SEC file number for Axsome Therapeutics, Inc.?
The SEC File Number for Axsome Therapeutics, Inc. is 001-37635.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding Axsome Therapeutics, Inc. (AXSM).